Neoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma

Clinical trial NCT07349303 · RECRUITING

Trial details

NCT number: NCT07349303
Sponsor: Vastra Gotaland Region
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin Cancer)

Start date: 2026-01-15
Primary completion: 2029-05-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.